239 related articles for article (PubMed ID: 9165528)
1. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody.
Duddu SP; Dal Monte PR
Pharm Res; 1997 May; 14(5):591-5. PubMed ID: 9165528
[TBL] [Abstract][Full Text] [Related]
2. The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody.
Duddu SP; Zhang G; Dal Monte PR
Pharm Res; 1997 May; 14(5):596-600. PubMed ID: 9165529
[TBL] [Abstract][Full Text] [Related]
3. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation.
Breen ED; Curley JG; Overcashier DE; Hsu CC; Shire SJ
Pharm Res; 2001 Sep; 18(9):1345-53. PubMed ID: 11683251
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Predictors of Protein Relative Stability Obtained by Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR.
Fang R; Obeidat W; Pikal MJ; Bogner RH
Pharm Res; 2020 Aug; 37(9):168. PubMed ID: 32794130
[TBL] [Abstract][Full Text] [Related]
5. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
Zeng XM; Martin GP; Marriott C
Int J Pharm; 2001 May; 218(1-2):63-73. PubMed ID: 11337150
[TBL] [Abstract][Full Text] [Related]
6. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
Tang XC; Pikal MJ
Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
[TBL] [Abstract][Full Text] [Related]
8. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms.
Chen B; Bautista R; Yu K; Zapata GA; Mulkerrin MG; Chamow SM
Pharm Res; 2003 Dec; 20(12):1952-60. PubMed ID: 14725359
[TBL] [Abstract][Full Text] [Related]
9. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
Chang BS; Beauvais RM; Dong A; Carpenter JF
Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
[TBL] [Abstract][Full Text] [Related]
10. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
11. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
12. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state.
Chang LL; Shepherd D; Sun J; Tang XC; Pikal MJ
J Pharm Sci; 2005 Jul; 94(7):1445-55. PubMed ID: 15920766
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
Yoshioka S; Aso Y
Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
[TBL] [Abstract][Full Text] [Related]
14. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
Yoshioka S; Miyazaki T; Aso Y
Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
[TBL] [Abstract][Full Text] [Related]
15. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.
te Booy MP; de Ruiter RA; de Meere AL
Pharm Res; 1992 Jan; 9(1):109-14. PubMed ID: 1589394
[TBL] [Abstract][Full Text] [Related]
17. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
18. Freeze-Drying Above the Glass Transition Temperature in Amorphous Protein Formulations While Maintaining Product Quality and Improving Process Efficiency.
Depaz RA; Pansare S; Patel SM
J Pharm Sci; 2016 Jan; 105(1):40-9. PubMed ID: 26580140
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?
Chang L; Shepherd D; Sun J; Ouellette D; Grant KL; Tang XC; Pikal MJ
J Pharm Sci; 2005 Jul; 94(7):1427-44. PubMed ID: 15920775
[TBL] [Abstract][Full Text] [Related]
20. Glass fragility and the stability of pharmaceutical preparations--excipient selection.
Hatley RH
Pharm Dev Technol; 1997 Aug; 2(3):257-64. PubMed ID: 9552453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
